Quantbot Technologies’s Ascendis Pharma A/S ASND Stock Holding History

Quantbot Technologies’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,900	Closed	-$590K	–	1422
2024 Q1	$590K	Sell	3,900 -1,400	-26%	-$200K	0.03%	690
2023 Q4	$668K	Buy	+5,300	New	+$528K	0.04%	625
2021 Q4	–	Sell	-3,700	Closed	-$589K	–	1484
2021 Q3	$589K	Buy	+3,700	New	+$506K	0.04%	550
2020 Q4	–	Sell	-200	Closed	-$30K	–	1273
2020 Q3	$30K	Buy	+200	New	+$28.7K	﹤0.01%	946
2019 Q4	–	Sell	-300	Closed	-$28K	–	1208
2019 Q3	$28K	Buy	+300	New	+$33.5K	﹤0.01%	1070
2018 Q3	–	Sell	-1,789	Closed	-$119K	–	1246
2018 Q2	$119K	Sell	1,789 -1,504	-46%	-$98.9K	0.01%	844
2018 Q1	$215K	Buy	+3,293	New	+$185K	0.02%	672

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantbot Technologies's ASND Position: Q2 2024 in Review

Quantbot Technologies sold out of Ascendis Pharma A/S (ASND) in Q2 2024, closing a stake of 3,900 shares — an estimated $590K sold.

Quantbot Technologies first reported a position in ASND in Q1 2018 and held it in 7 quarters. The position peaked at $668K in Q4 2023. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.

Quantbot Technologies reported no remaining Ascendis Pharma A/S position as of Q2 2024 after selling out during the quarter.
Quantbot Technologies sold 3,900 Ascendis Pharma A/S shares in Q2 2024, an estimated $590K.
Quantbot Technologies first reported a position in Ascendis Pharma A/S in Q1 2018 and held it in 7 quarters.
Quantbot Technologies's Ascendis Pharma A/S position peaked at $668K in Q4 2023.
203 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.